Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina
- PMID: 12241831
- DOI: 10.1016/s0140-6736(02)09894-x
Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina
Abstract
Background: Current guidelines suggest that, for patients at moderate risk of death from unstable coronary-artery disease, either an interventional strategy (angiography followed by revascularisation) or a conservative strategy (ischaemia-driven or symptom-driven angiography) is appropriate. We aimed to test the hypothesis that an interventional strategy is better than a conservative strategy in such patients.
Methods: We did a randomised multicentre trial of 1810 patients with non-ST-elevation acute coronary syndromes (mean age 62 years, 38% women). Patients were assigned an early intervention or conservative strategy. The antithrombin agent in both groups was enoxaparin. The co-primary endpoints were a combined rate of death, non-fatal myocardial infarction, or refractory angina at 4 months; and a combined rate of death or non-fatal myocardial infarction at 1 year. Analysis was by intention to treat.
Findings: At 4 months, 86 (9.6%) of 895 patients in the intervention group had died or had a myocardial infarction or refractory angina, compared with 133 (14.5%) of 915 patients in the conservative group (risk ratio 0.66, 95% CI 0.51-0.85, p=0.001). This difference was mainly due to a halving of refractory angina in the intervention group. Death or myocardial infarction was similar in both treatment groups at 1 year (68 [7.6%] vs 76 [8.3%], respectively; risk ratio 0.91, 95% CI 0.67-1.25, p=0.58). Symptoms of angina were improved and use of antianginal medications significantly reduced with the interventional strategy (p<0.0001).
Interpretation: In patients presenting with unstable coronary-artery disease, an interventional strategy is preferable to a conservative strategy, mainly because of the halving of refractory or severe angina, and with no increased risk of death or myocardial infarction.
Comment in
-
Non-ST-elevation acute coronary syndrome: fuel for the invasive strategy.Lancet. 2002 Sep 7;360(9335):738-9. doi: 10.1016/S0140-6736(02)09945-2. Lancet. 2002. PMID: 12241827 No abstract available.
-
The RITA 3 trial.Lancet. 2002 Dec 14;360(9349):1971; author reply 1973-4. doi: 10.1016/S0140-6736(02)11863-0. Lancet. 2002. PMID: 12493282 No abstract available.
-
The RITA 3 trial.Lancet. 2002 Dec 14;360(9349):1971-2; author reply 1973-4. doi: 10.1016/S0140-6736(02)11864-2. Lancet. 2002. PMID: 12493283 No abstract available.
-
The RITA 3 trial.Lancet. 2002 Dec 14;360(9349):1972; author reply 1973-4. doi: 10.1016/S0140-6736(02)11865-4. Lancet. 2002. PMID: 12493284 No abstract available.
-
The RITA 3 trial.Lancet. 2002 Dec 14;360(9349):1972-3; author reply 1973-4. doi: 10.1016/S0140-6736(02)11866-6. Lancet. 2002. PMID: 12493285 No abstract available.
-
The RITA 3 trial.Lancet. 2002 Dec 14;360(9349):1973; author reply 1973-4. doi: 10.1016/S0140-6736(02)11867-8. Lancet. 2002. PMID: 12493286 No abstract available.
-
Revascularization not superior to conservative treatment of acute coronary syndromes.J Fam Pract. 2002 Dec;51(12):1011. J Fam Pract. 2002. PMID: 12540320
-
An interventional strategy was better than a conservative strategy in unstable angina or non-ST-elevation MI.ACP J Club. 2003 Mar-Apr;138(2):32. ACP J Club. 2003. PMID: 12614117 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical